(1) Adjusted Net income, Adjusted earnings per share basic and Adjusted earnings per share diluted are non-GAAP measures. Please see EXHIBIT I at the end of this release for a reconciliation to ...
Star Bulk Carriers Corp (NASDAQ:SBLK) is set to release its Q4 2024 earnings on Feb 18, 2025. The consensus estimate for Q4 2024 revenue is $0.23 billion, and the earnings are expected to come in ...
Star Bulk Carriers Corp., a shipping company, engages in the ocean transportation of dry bulk cargoes worldwide. Its vessels transport a range of bulk commodities, including iron ores, minerals ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
Its biggest competitor is GSK, which also has a new dual bronchodilator Anoro Ellipta ... once-daily dose in GSK’s Ellipta dry powder inhaler. Novartis says its results support recommendations ...
It also lowers the risk of an asthma attack. Airsupra comes as an aerosol that you inhale through your mouth via the Airsupra inhaler. Airsupra contains the active ingredients albuterol and ...
Trelegy Ellipta comes as a powder you inhale into your lungs using the Ellipta inhaler. If you and your doctor determine Trelegy Ellipta is safe and effective for you, you’ll likely use it long ...
The products covered under the bill include beta-blockers for people with congestive heart failure, blood pressure monitors for people with hypertension, glucometers for people with diabetes, inhalers ...
Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...
The acquisition is in line with CMB.TECH’s strategic objective of diversification, with the company intending to become a long-term shareholder in Golden Ocean and investing in a modern dry bulk fleet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results